{"id":"NCT02265237","sponsor":"AbbVie","briefTitle":"A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)","officialTitle":"A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-28","primaryCompletion":"2016-07-28","completion":"2017-04-07","firstPosted":"2014-10-15","resultsPosted":"2017-08-31","lastUpdate":"2017-08-31"},"enrollment":184,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus"],"interventions":[{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir","otherNames":["norvir (ritonavir)","paritaprevir (ABT-450)","ombitasvir (ABT-267)"]},{"type":"DRUG","name":"ribavirin","otherNames":[]}],"arms":[{"label":"Arm A","type":"EXPERIMENTAL"},{"label":"Arm B","type":"EXPERIMENTAL"},{"label":"Arm C","type":"EXPERIMENTAL"},{"label":"Arm D","type":"EXPERIMENTAL"}],"summary":"The purpose of this study in HCV genotype 4-infected participants with compensated cirrhosis is to assess the safety and to compare the percentage of participants achieving a 12-week sustained virologic response (SVR12), \\[HCV ribonucleic acid (RNA) \\< lower limit of quantification (LLOQ) 12 weeks following treatment\\], to a clinically relevant threshold \\[based on SVR rates for HCV genotype 4-infected participants treated with pegylated interferon (pegIFN)/RBV\\].","primaryOutcome":{"measure":"Percentage of Participants in Arms A, B and C With Sustained Virologic Response 12 Weeks Post-treatment (SVR12)","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"Arm A","deltaMin":96.6,"sd":null},{"arm":"Arm B","deltaMin":100,"sd":null},{"arm":"Arm C","deltaMin":93.4,"sd":null}],"pValues":[{"comp":"OG001","p":null},{"comp":"OG000","p":null},{"comp":"OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28404108"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":60},"commonTop":["ASTHENIA","FATIGUE","HEADACHE","PRURITUS","ANAEMIA"]}}